# Courier Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/courier-health

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.courierhealth.com
- Total disclosed funding: $71M
- Latest round: Series B (Apr 22, 2026)
- Investors on record: 4

## About

Courier Health, Inc. is a US-based company that specializes in providing a Patient Relationship Management (CRM) platform specifically for the life sciences industry, enhancing patient engagement and operational efficiency for biopharma organizations.Courier Health, Inc. was founded in 2021 in New York, US. The company focuses on revolutionizing patient management for biopharma commercial organizations through its tailored CRM platform. The founders, Danny Sigurdson and Jimmy Pomponio, have experience in the industry, with Danny Sigurdson serving as the current CEO. In July 2024, Courier Health raised USD 16.5 mn in Series A funding, led by Norwest Venture Partners, contributing to a total amount raised of USD 16.5 mn with a current company valuation of USD 56.86 mn.  The firm has completed 3 deals to date, with the most recent taking place on July 9, 2024.Courier Health specializes in a purpose-built Patient Relationship Management (CRM) platform tailored for the life sciences sector, primarily serving biopharma commercial organizations. This CRM platform offers solutions designed to manage the patient journey from awareness through adherence, providing real-time visibility into patient data, omnichannel workflow management, and compliance coordination. The platform is utilized by biopharma teams to reduce operational complexities and ensure patient therapy adherence, serving clients across North America and Europe, including both large pharmaceutical companies and smaller biopharma firms.Courier Health adopts a subscription-based revenue model, allowing clients to pay for access to its CRM platform and associated services. Clients typically enter into contracts with annual subscriptions for comprehensive access to features, including a command center for managing the patient journey. This pricing reflects the value provided through enhanced engagement and operational efficiencies, with tailored rates for different organizations. The flagship product, the Patient CRM for life sciences, is central to these transactions, equipping clients with necessary tools for effective patient management and compliance.In July 2024, Courier Health raised USD 16.5 mn in Series A funding, led by Norwest Venture Partners, to support product innovation and enhance hiring in engineering and sales to improve its CRM platform. The company is focusing on expanding into new markets and geographic regions, particularly targeting further growth in Europe and enhancing its product offerings. The management plans to launch new features within its CRM platform to better serve the evolving needs of biopharma clients.

## Funding rounds

- Series B, Apr 22, 2026, $50M — Norwest Venture Partners, Work-Bench Management, Oak HC/FT
- Series A, Jul 9, 2024, $17M — Norwest Venture Partners, Work-Bench
- Seed, Sep 9, 2021, $4M — Work-Bench

## Investors

- Work-Bench — Seed, Series A
- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series A, Series B
- Work-Bench Management (https://capitalatlas.ai/funds/work-bench-management) — Series B
- Oak HC/FT (https://capitalatlas.ai/funds/oak-hc-ft) — Series B